Present address: Department of Oncology and Lombardi Comprehensive Cancer Center, Georgetown University Medical Center, Washington, District of Columbia, USA.
Sensitivity and kinase activity of epidermal growth factor receptor (EGFR) exon 19 and others to EGFR-tyrosine kinase inhibitors
Article first published online: 28 MAR 2013
© 2013 Japanese Cancer Association
Volume 104, Issue 5, pages 584–589, May 2013
How to Cite
(Cancer Sci 2013; 104: 584–589)
- Issue published online: 15 APR 2013
- Article first published online: 28 MAR 2013
- Accepted manuscript online: 7 FEB 2013 05:42AM EST
- Manuscript Accepted: 29 JAN 2013
- Manuscript Revised: 21 JAN 2013
- Manuscript Received: 9 DEC 2012
|cas12125-sup-0001-DocS1.docx||Word document||22K||Doc. S1. List of the primers for site-directed mutagenesis.|
|cas12125-sup-0002-TableS1.xlsx||application/msexcel||11K||Table S1. Patients' characteristics and serum concentration of epidermal growth factor receptor-tyrosine kinase inhibitors in this study.|
Please note: Wiley Blackwell is not responsible for the content or functionality of any supporting information supplied by the authors. Any queries (other than missing content) should be directed to the corresponding author for the article.